Janus Henderson Global Life Sciences Fund (JAGLX) is an MF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 8.84% of fund assets.
Janus Henderson Global Life Sciences Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- JAGLX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
8.84% | $459,405,799.83 | 499,479 |
|
-
JOHNSON & JOHNSON
|
7.29% | $378,940,665.60 | 1,550,240 |
|
-
ASTRAZENECA PLC
|
4.59% | $238,631,842.21 | 1,221,946 |
|
-
AbbVie Inc.
|
4.05% | $210,526,622.67 | 967,983 |
|
-
UNITEDHEALTH GROUP INC
|
3.13% | $162,689,802.19 | 601,241 |
|
-
NOVARTIS AG
|
2.86% | $148,414,802.25 | 971,619 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
2.51% | $130,390,620.75 | 265,275 |
|
-
Praxis Precision Medicines, Inc.
|
2.45% | $127,255,384.30 | 394,970 |
|
-
ARGENX SE
|
2.40% | $124,748,607.50 | 170,830 |
|
-
ABBOTT LABORATORIES
|
2.40% | $124,487,066.99 | 1,212,497 |
|
-
BridgeBio Pharma, Inc.
|
2.22% | $115,187,730.66 | 1,551,141 |
|
-
ROCHE HOLDING AG /CHF/
|
2.21% | $114,896,793.77 | 290,904 |
|
-
Sanofi
|
2.07% | $107,723,985.60 | 1,116,972 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.06% | $107,134,769.88 | 239,922 |
|
-
Revolution Medicines, Inc.
|
2.04% | $105,809,750.50 | 1,088,018 |
|
-
INTUITIVE SURGICAL INC
|
2.02% | $104,791,785.81 | 227,319 |
|
-
HCA Healthcare, Inc.
|
1.88% | $97,767,598.08 | 206,592 |
|
-
BOSTON SCIENTIFIC CORP
|
1.84% | $95,387,341.75 | 1,520,117 |
|
-
AMGEN INC
|
1.83% | $95,030,814.65 | 270,089 |
|
-
Ascendis Pharma A/S
|
1.65% | $85,815,607.59 | 375,183 |
|
-
STRYKER CORP
|
1.65% | $85,710,401.37 | 260,843 |
|
-
DANAHER CORP /DE/
|
1.64% | $85,048,303.20 | 448,567 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
1.50% | $78,099,106.65 | 149,195 |
|
-
CVS HEALTH Corp
|
1.48% | $76,983,427.08 | 1,071,894 |
|
-
Merck & Co., Inc.
|
1.48% | $76,814,066.46 | 638,574 |
|
-
PTC THERAPEUTICS, INC.
|
1.34% | $69,776,906.49 | 1,024,173 |
|
-
UNITED THERAPEUTICS Corp
|
1.33% | $69,213,218.58 | 116,721 |
|
-
MCKESSON CORP
|
1.33% | $69,071,304.48 | 79,818 |
|
-
GILEAD SCIENCES, INC.
|
1.26% | $65,738,180.97 | 471,681 |
|
-
GLOBUS MEDICAL INC
|
1.24% | $64,499,720.64 | 748,604 |
|
-
Mirum Pharmaceuticals, Inc.
|
1.22% | $63,324,827.16 | 685,482 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.18% | $61,368,927.72 | 2,037,481 |
|
-
Vaxcyte, Inc.
|
1.09% | $56,467,637.07 | 971,737 |
|
-
Medtronic plc
|
0.97% | $50,554,382.80 | 583,432 |
|
-
Elevance Health, Inc.
|
0.93% | $48,387,183.75 | 165,285 |
|
-
Dyne Therapeutics, Inc.
|
0.88% | $45,836,701.12 | 2,528,224 |
|
-
Cencora, Inc.
|
0.84% | $43,708,811.32 | 139,138 |
|
-
Travere Therapeutics, Inc.
|
0.82% | $42,549,592.44 | 1,432,164 |
|
-
Lantheus Holdings, Inc.
|
0.76% | $39,349,918.10 | 518,786 |
|
-
Medline Inc.
|
0.74% | $38,470,739.50 | 864,511 |
|
-
Edwards Lifesciences Corp
|
0.72% | $37,283,566.32 | 465,579 |
|
-
DEXCOM INC
|
0.68% | $35,261,634.80 | 561,491 |
|
-
SOLENO THERAPEUTICS INC
|
0.64% | $33,070,874.40 | 987,780 |
|
-
APOGEE THERAPEUTICS INC
|
0.61% | $31,951,605.36 | 379,608 |
|
-
UCB SA
|
0.61% | $31,490,705.78 | 104,561 |
|
-
BECTON DICKINSON & CO
|
0.55% | $28,549,351.71 | 181,577 |
|
-
GLAUKOS Corp
|
0.55% | $28,498,032.64 | 264,704 |
|
-
Structure Therapeutics Inc.
|
0.53% | $27,454,189.80 | 569,589 |
|
-
IDEAYA Biosciences, Inc.
|
0.47% | $24,615,083.36 | 738,748 |
|
-
Penumbra Inc
|
0.47% | $24,212,690.32 | 73,736 |
Advertisement (320x50)